Search - tctmd.com

Displaying 1 - 20 of 290

Sort: Relevancy | Date

News Daily News

Public Reporting Tied to Better Care, but Similar Outcomes, in Stroke Centers

Todd Neale

January 16, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2025

Michael O'Riordan

December 29, 2025

News Daily News

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Todd Neale

December 26, 2025

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

News Conference News VIVA 2025

ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss

L.A. McKeown

November 07, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Conference News ESC 2025

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

L.A. McKeown

September 05, 2025

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Caitlin E. Cox

September 01, 2025

News Daily News

Gut Microbes Linked to Risk of Abdominal Aortic Aneurysms

Michael O'Riordan

August 20, 2025

News Conference News EuroPCR 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Michael O'Riordan

May 23, 2025

News Conference News ESOC 2025

IV Tenecteplase Helps Before Stroke Thrombectomy: BRIDGE-TNK

Todd Neale

May 22, 2025

News Conference News CX Symposium 2025

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

L.A. McKeown

April 30, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2025

Caitlin E. Cox

April 30, 2025

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

News Daily News

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Michael O'Riordan

March 04, 2025

News Daily News

Survey Calls Out Implicit Bias in Peripheral Vascular Care

L.A. McKeown

February 28, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2025

Shelley Wood

February 28, 2025

News Daily News

AHA Scientific Statement Takes Aim at PAD Pain

L.A. McKeown

February 13, 2025

Advertisement

Public Reporting Tied to Better Care, but Similar Outcomes, in Stroke Centers

TCTMD’s Top 10 Most Popular Stories for December 2025

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

December 2025 Dispatch for the CV Team

ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss

CVD Still the Leading Cause of Death and Disease Globally

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Gut Microbes Linked to Risk of Abdominal Aortic Aneurysms

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

IV Tenecteplase Helps Before Stroke Thrombectomy: BRIDGE-TNK

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

TCTMD’s Top 10 Most Popular Stories for April 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Survey Calls Out Implicit Bias in Peripheral Vascular Care

TCTMD’s Top 10 Most Popular Stories for February 2025

AHA Scientific Statement Takes Aim at PAD Pain

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content